Fallopian Tube Neoplasms

• CLINICAL_TRIALS trial_result · 2026-03-09
  Clinical Trial Update: Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65). [Phase 3]

  Phase 3 trial assessing pembrolizumab with paclitaxel, with or without bevacizumab, for platinum-resistant recurrent ovarian cancer; results…

• CLINICAL_TRIALS trial_result · 2021-01-20
  Clinical Trial Update: Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy

  Clinical trial evaluating whether fallopian tube cells collected by Cytuity can determine the presence of malignancy compared with removed o…

• CLINICAL_TRIALS trial_result · 2020-11-10
  Clinical Trial Update: Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer [Phase 2]

  Phase 2 trial evaluating niraparib in combination with bevacizumab for platinum-refractory/resistant recurrent ovarian cancer; efficacy and …

• CLINICAL_TRIALS trial_result · 2020-10-19
  Clinical Trial Update: Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill") [Phase 2]

  Phase 2 trial comparing standard chemotherapy plus enzastaurin versus placebo in ovarian cancer; completed with results posted.

• CLINICAL_TRIALS trial_result · 2006-10-02
  Clinical Trial Update: Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response [Phase 1, Phase 2]

  Phase 1/2 clinical trial evaluating ACA 125 in patients with ovarian cancer, focusing on safety and immune response.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.